+44 (0)1865 595230 nac.contact@lgcgroup.com
0 Items
Select Page

Candida Albicans

Candida albicans is the commonest fungal pathogen of humans and generally resides harmlessly as a commensal microbe. However, when not kept in check by the immune system it can cause extensive morbidity, particularly in immunocompromised individuals or those with implanted medical devices. It is one of the most frequent hospital acquired infections and correspondingly places a significant economic burden on healthcare systems worldwide.

Candida Albicans Background

Of millions of fungal species, only around 600 spp. are human pathogens (Brown et al., 2012). These include fungi that cause relatively mild infections of the skin (such as dermatophytes and Malassezia spp.), fungi that cause severe cutaneous infections (e.g. Sporotrix schenkii) and fungi that have the potential to cause life-threatening systemic infections (such as Aspergillus fumigatus, Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans) (Mayer et al., 2013). C. albicans can cause two major types of infections in humans: superficial infections, such as oral or vaginal candidiasis, and life-threatening systemic infections such as hematogenously disseminated infection with sizable mortality rates (approaching 40% in some cases) (Mayer et al., 2013; Nobile & Johnson, 2015).

Candida albicans is the most common serious fungal pathogen of humans, causing 250,000 to 400,000 deaths per year worldwide and ~100 million episodes of recurrent vaginitis. It is a classical opportunistic pathogen residing harmlessly as a commensal in approximately 50% of individuals, and kept in check by our immune system and a protective bacterial microbiome of the gut and other mucosal surfaces (Da Silva Dantas et al., 2016). C. albicans can also survive outside of the human body. Within humans, it is a member of the healthy microbiota, asymptomatically colonizing the gastrointestinal (GI) tract, reproductive tract, oral cavity, and skin of most people. In individuals with healthy immune systems, it is kept in balance with other members of the local microbiota and is generally harmless. However, changes in the host microbiota (e.g., due to antibiotics), changes in the host immune response (e.g., during stress, infection by another microbe, or immunosuppressant therapy), or variations in the local environment (e.g., shifts in pH or nutritional content) can allow it to overgrow and cause infection. These infections are especially serious in immunocompromised individuals (such as those with AIDS or those undergoing anticancer or immunosuppression therapies) and healthy people with implanted medical devices (Nobile & Johnson, 2015). Recent studies also suggest that C. albicans can cross the blood brain barrier (Wu et al., 2019).

C. albicans is a polymorphic fungus and can transition between yeast and hyphal forms (dimorphism). It can grow either as an ovoid-shaped budding yeast, as elongated ellipsoid cells with constrictions at the septa (pseudohyphae) or as parallel-walled true hyphae. Other morphologies include white and opaque cells, formed during switching, and chlamydospores, which are thick-walled spore-like structures. Both growth forms are important for pathogenicity but the hyphal form has been shown to be more invasive than the yeast form (Mayer et al., 2013). C. albicans also grows as a highly structured biofilm, forming a community of adherent cells attached to solid surfaces, such as implanted medical devices, including catheters, pacemakers, dentures, and prosthetic joints or at liquid-air interfaces. Biofilms are often resistant to conventional antifungal therapeutics, the host immune system, and other environmental perturbations, and biofilm-based infections present a significant clinical challenge (Nobile & Johnson, 2015). Recent estimates by the National Institutes of Health suggest that pathogenic biofilms are responsible, directly or indirectly, for over 80% of all microbial infections (Nobile & Johnson, 2015). Resistance to anti-fungals is increasingly becoming a problem, particularly as there are only a limited number available. One of the problems in developing more is that in contrast to bacteria, fungi are often overlooked as a potential health problem (Nat Microbiol., 2017).


  • Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119‐128.
  • Brown GD, Denning DW, Levitz SM. Tackling human fungal infections. Science. 2012 May 11; 336(6082):647.
  • da Silva Dantas A, Lee KK, Raziunaite I, et al. Cell biology of Candida albicans-host interactions. Curr Opin Microbiol. 2016;34:111‐118.
  • Nobile CJ, Johnson AD. Candida albicans Biofilms and Human Disease. Annu Rev Microbiol. 2015;69:71‐92.
  • Wu Y, Du S, Johnson JL, et al. Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits. Nat Commun. 2019;10(1):58.
  • Stop neglecting fungi. Nat Microbiol. 2017;2:17120.

Candida Albicans Antigens

We are pleased to offer a native antigen consisting of cytoplasmic and cell wall components for C. albicans for use in diagnostic research and development.


Check out our FAQ section for answers to the most frequently asked questions about our website and company.

COVID-19 Underlines the Need for Universal Vaccines

This article was originally published on Clinical Lab Manager. In recent history, humanity has witnessed numerous emerging viral diseases, including the SARS, MERS, and SARS-2 coronaviruses, as well as HIV, Zika, Ebola, and H1N1 and H3N2 influenza. None have tested...

Tick-Borne Diseases: The Need for Integrated Approaches to Human-Animal Diagnosis

This article has been published in Volume 8, Issue 3 of International Animal Health Journal. Ticks are responsible for a diverse group of neglected, and rapidly expanding diseases, affecting humans, companion animals and livestock. A growing understanding of tick-host...

The Continued Challenges of Flavivirus Serology

This article was originally published on the Science Advisory Board. Flaviviruses are a genus of positive-sense RNA viruses, largely transmitted by mosquito and tick vectors that cause infections, including yellow fever, dengue, the Zika virus, West Nile virus,...

The Role of Serology in Tracking COVID-19 Mutations

This article was originally published on Clinical Lab Products. As SARS-CoV-2 began its global proliferation in early 2020, scientists hastened to investigate its biology, develop diagnostic tests, and design candidate vaccines, marking one of the most...

Preparing for Disease Y: A Better Serological Toolbox

This article was originally published on Clinical Lab Manager. It’s been over a year since the World Health Organization (WHO) declared COVID-19 a pandemic. SARS-CoV-2 has since infected 200 million people, resulting in nearly 4 million deaths and substantial economic...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

11 + 15 =